PIK3CA and diffuse intrinsic pontine glioma: This prompted a combination of ONC201 with paxalisib, a PI3K inhibitor, and this combination demonstrated tumor regression and prolonged survival in diffuse intrinsic pontine glioma (DIPG) patients [30].